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a b s t r a c t
Many radiotherapy research centers have recently installed novel research platforms enabling the inves-
tigation of the radiation response of tumors and normal tissues in small animal models, possibly in com-
bination with other treatment modalities. Many more research institutes are expected to follow in the
coming years. These novel platforms are capable of mimicking human radiotherapy more closely than
older technology. To facilitate the optimal use of these novel integrated precision irradiators and various
small animal imaging devices, and to maximize the impact of the associated research, the ESTRO commit-
tee on coordinating guidelines ACROP (Advisory Committee in Radiation Oncology Practice) has commis-
sioned a report to review the state of the art of the technology used in this new field of research, and to
issue recommendations. This report discusses the combination of precision irradiation systems, small
animal imaging (CT, MRI, PET, SPECT, bioluminescence) systems, image registration, treatment planning,
and data processing. It also provides guidelines for reporting on studies.
 2017 The Authors. Published by Elsevier Ireland Ltd. Radiotherapy and Oncology xxx (2017) xxx–xxx
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).
Translational and radiobiological research is currently undergo-
ing a revolution due to two key developments: (1) the availability
of advanced tumor models with more clinically relevant tumor
environments, and (2) the availability of technology that allows
precise radiation targeting, using onboard integrated image-
guidance which can mimic clinically advanced radiotherapy treat-
ments in an experimental setting (Fig. 1). Such precision irradiators
facilitate studies that explore temporal and spatial dose modula-
tion, and novel combinations of radiation with other therapeutic
or protective agents, both for radiation response of tumors and
normal tissues. The aim of these studies is then to generate results
that can be translated more rapidly into clinical trials, benefitting
patients [1,2].
These new technologies, for small animal research, bring an
extensive range of challenges that need careful assessment to
allow their future optimal use for translational research. Specific
challenges include: (1) What are the key technologies required to
downscale clinical treatments into small animal models? (2)
How to deal with target motion? (3) Which imaging modalities
should be integrated into the radiation platforms? (4) What are
the optimal irradiation margins? (5) What is the accuracy and pre-
cision of small field dosimetry? (6) Which methods should be
developed to verify the dose distribution? (7) Which imaging
modalities should be used for treatment planning, given the evolv-
ing clinical scenarios? (8) What is the difference between high and
low-energy photon irradiation?
In the framework of ACROP (ESTRO’s Advisory Committee in
Radiation Oncology Practice), the ESTRO committee coordinating
guidelines, this newly established writing committee’s mandate
is to review and discuss the state of the art in this new field of
research, covering the technology [3,4] currently available for
image-guided small animal radiation research such as precision
https://doi.org/10.1016/j.radonc.2017.11.016
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irradiation systems, imaging (CT, MRI, PET, SPECT, biolumines-
cence) systems, image registration, treatment planning, and data
processing. Finally, animal radiation research with light ion beams
is also briefly addressed, although the latter is usually not per-
formed with dedicated small animal beams, but rather with spe-
cialized setups at ion beams for radiotherapy.
Basically, three categories of users of radiation in animal studies
can be identified: ones that need a known arbitrary but repro-
ducible radiation dose (e.g. to study synergistic effects), ones that
need a precise dose or range of doses (e.g. to establish a dose–re-
sponse curve) and ones that need a modulated dose distribution
(in time and/or space). This review is intended to be a first step
toward aiding users to define optimal studies and toward guiding
developers with respect to future improvements, with a strong
focus on the latter two categories.
Commissioning and operating precision irradiators
Preclinical research platforms which have been developed,
commercially or otherwise, are summarized in Table 1. The preci-
sion and accuracy of the novel irradiators are critically dependent
on how well they have been commissioned and the subsequent
quality control [5–7].
Table S1 lists the main issues that need to be considered during
commissioning. Ideally commissioning should be performed by a
medical/radiation physicist, who has expertise in radiation source
commissioning using suitable phantoms. For inexperienced users,
commissioning may be done by the manufacturer, but in this case
it is recommended that a report is provided with the raw data and
any processed data. A key part of this is absolute dosimetry using
standardized protocols (e.g. [18–20]) and calibrated equipment
traceable to a primary standard. To ensure continuous accuracy it
is essential that regular quality assurance measurements are made,
this may vary from daily for critical but simple output checks, to
monthly for more detailed checks. If real-time dosimetry is desired,
small radiation detectors such as mosfets or optical fibers may be
considered, or the onboard X-ray imager may be used to verify
the treatment [21].
In practice the dose distribution is dependent on many factors,
including the photon spectrum, irradiation geometry, the composi-
tion and geometry/anatomy of the animal being irradiated and sur-
rounding scattering/attenuating materials. Each of these needs to
be adequately described along with the details of the dose mea-
surement/calculation. In addition to the physical dose, the ultimate
biological response can also depend on factors such as dose rate
and radiation quality [22,23]. Unfortunately, the experimental
setup, dosimetry and exposure details are often inadequately
reported in the scientific literature, emphasizing the necessity to
develop standard operating procedures [24,25] with the key issues
summarized in Table S2. This information is required to assess the
quality and limitations of preclinical data, to ensure that any
effects observed are not artifactual, and thus to evaluate the trans-
lational potential of the data and hypotheses generated for the
development of clinical trials [26].
Recommendations for reporting studies can be found in Table 2.
Treatment planning systems
Treatment planning systems (TPS) for small animal irradiators
face several challenges [27]. Commonly, the target volume is small,
rarely exceeding a cubic cm. Thus, irradiation is preferentially per-
formed with about 225 kV instead of MV photon beams to avoid
large dose-build-up effects at medium interfaces and wide penum-
brae [4]. Together with the small field sizes, this renders calcula-
tion models implemented in clinical MV treatment planning
systems (TPS) unsuitable, since apart from Compton scatter the
tissue-dependent photo-electric effect needs to be considered,
and the resulting inaccuracies for small beams would be unaccept-
able [27]. Different calculation models have been implemented in
small animal irradiators with Monte Carlo simulation and
Superposition-Convolution being the most prominent ones
[4,6,21,28–31] (Table 3).
The workflow of preclinical treatment planning generally mim-
ics clinical radiotherapy (Fig. 2). The main difference is that treat-
ment planning and dose administration are performed in one
session while the animal is under anesthesia. Multi-modal func-
tional or molecular imaging is also available for preclinical treat-
ment planning [32], see also subsection on imaging devices.
Despite all technical advances in preclinical treatment planning,
several critical issues still remain. As such, commissioning of the
TPS represents major challenges (Table S3), particularly for very
small beams [6,7,33]. Moreover, photon scatter is poorly studied
for narrow beams of kV energies in small animals. It may interfere
with CBCT imaging quality as well as with accuracy of dose
calculation [7]. The procedure of tissue segmentation also involves
several open issues, including the aspect of arbitrariness and the
Fig. 1. Generic sketch of an image-guided precision irradiator. In this implemen-
tation radiation can be administered in an arc, and cone beam CT imaging is
performed by a rotating gantry mounted X-ray panel. In other implementations the
animal may rotate to acquire a CT image. In this example there is also a
bioluminescent camera mounted on the gantry, which allows capturing optical
photons emitted by labeled structures in the animal. Once the target volume has
been identified, a collimated X-ray beam is used to deliver the therapeutic dose,
either in the form on multiple stationary beams or a continuous arc.
Table 1
Examples of commercial and non-commercial image-guided small animal irradiators.
Commercial Non-commercial research machines
SARRP system (Xstrahl Ltd, UK) [8–10];
X-RAD 225Cx (Precision X-ray Inc., USA) [11]
Brachytherapy-based system using an Ir-192 source [12]
System based on the GE micro-CT scanner [5,13,14]
X-ray image guidance system [15]
Carbon nanotube [16]
SAIGRT system [17]
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question how many tissue types are needed for proper dose calcu-
lation accuracy [34–36]. Dose reporting is another concern. Dose-
to-water-in-medium and dose-to-medium-in-medium are two
completely different quantities which are currently used in paral-
lel, and it is so far entirely unclear which one correlates better with
the biological effects of ionizing irradiation. Both should be avail-
able but conversion from one to the other introduces uncertainties
[27]. As small animal planning will become more complicated,
beam optimization will be needed [37,38]. Finally, intra-
irradiation motion is a largely understudied aspect in preclinical
radiotherapy which may be addressed by time-resolved imaging,
gated beam delivery, and/or target tracking [39,91].
Image guidance systems
In the following sections we will discuss the commissioning and
operation of various small animal imaging methods for precision
irradiation. A recent report covered animal imaging quality control
[42]. Table S4 gives an overview of guidelines and future develop-
ment for the various imaging modalities.
Computed tomography (CT)
CT is a pre-requisite for heterogeneity corrections in dose calcu-
lation [27,43] for treatment planning. CT images in DICOM format
can be visualized using common research software platforms (e.g.
MatLab, Osirix, 3D Slicer). There are different technological
solutions for preclinical CT [4,44]. Dedicated micro-CTs have a
rotating X-ray tube and imaging panel configuration. Modern ani-
mal research platforms use either a fixed animal and rotating X-ray
tube/imager or vice versa, resulting in a cone beam CT (CBCT) scan.
Typical X-ray energies are between 35 and 90 keV. Amorphous sil-
icon imaging panels are standard, and image reconstruction is
based on the Feldkamp algorithm [45].
The technical realization and the underlying projection geome-
try vary and have a direct impact on the imaging parameters. There
are geometric aspects and accuracy requirements for irradiation
units with integrated CT imaging options, i.e. flex-correction maps
during imaging and irradiation need to be determined and verified
during regular quality assurance as well as Hounsfield Unit (HU)
calibration [7,42]. The mechanical hardware accuracy is reported
to be below 100 mm [15]. The typical image resolution (pixel
dimension) for CBCT is in the range of 100–200 mm, and even lower
for micro-CTs. The modulation transfer function (MTF) of CBCT and
micro-CT at the 10% level are around 1 mm1 and 2 mm1, respec-
tively. To determine spatial resolution, contrast, etc. dedicated
phantoms are required [46].
Imaging and treatments in the keV energy range imply the
availability of dedicated dosimetry equipment [18]. Typical imag-
ing doses to small animals are around 0.3 Gy or even higher for
micro-CT [47]; and need to be considered in longitudinal studies
especially for non-tumor tissue. Technical solutions for respiratory
motion management have been reported [48], and next generation
systems are expected to offer dual energy options [49].
Table 2
Requirements for specification and reporting of small animal irradiation with particle beams.
Common requirements for studies with photons and particles (See also Table S1)
Irradiation modality Photon energy, filtration, kVp, half value layer, particle type and particle energy
Absorbed dose Dose prescription point or volume, 1–2-3D dose distribution
Field size
Margins
Treatment fields Number, size and orientation of beams
Optimization Algorithm and parameters
Specific requirements for particle beam studies
Depth dose profile Pristine Bragg peak: energy and range of primary particles
Spread Out Bragg Peak: range and depth of the proximal and distal edge of high-dose region
Position of the target
tissue within the
beam
Linear Energy Transfer Track-averaged or dose-averaged LET or another beam quality specifier including range of LET
for extended targets
Setup Detailed information on of setup and range adjustment (collimators, range shifters)
SOBP Specification whether the SOBP was optimized in terms of absorbed or RBE-weighted dose. If the latter,
which RBE-model and model parameters were used, and the type of photon reference radiation
Table 3
Comparison of dose calculation models currently implemented in treatment planning systems of small animal precision irradiators.
Superposition–Convolution dose calculation Monte Carlo simulation
Principle Local photon energy fluence derived from the primary energy fluence
emanating from the photon source multiplied by energy absorption
coefficient gives total energy released to matter (terma). Ray-tracing
with inclusion of 1st order Compton scatter
Modeling of particle transport, interactions with other particles and
electromagnetic fields, and production of secondary particles based
on cross sections and transport theories. Consideration of Compton
scatter and photo-electric effect
Input Photon spectrum or phase space file obtained from separate Monte
Carlo simulation. Geometry and materials are defined from CT
images.
Photon spectrum or phase space file obtained from separate Monte
Carlo simulation. Geometry and materials are defined from CT
images.
Dose reporting Dose-to-water-in-medium, convertible into Dose-to-medium-in-
medium
Dose-to-medium-in-medium and dose-to-water-in-medium
Limitation Inaccuracies in non-water media with dose discontinuities (lung,
bone)




3D Slicer-based MuriPlan [40] MatLab-based SmART-Plan [41]*
* From July 2017 onward this is replaced by SmART-ATP (SmART Scientific Solutions BV, Maastricht, the Netherlands).
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Positron emission tomography (PET) and single photon
emission tomography (SPECT)
Treatment planning for preclinical precision irradiators is pre-
dominantly based on CT imaging. Additional information from
nuclear medicine based imaging techniques, i.e. PET and SPECT,
can be used for (sub-)target volume definition in dose painting
strategies, for response assessment in longitudinal studies, or in
the context of imaging and therapeutic biomarker research [50–53].
Image quality in SPECT/PET is mainly determined by spatial res-
olution and sensitivity. Recent SPECT cameras obtain sub-
millimeter spatial resolution using a multi-pinhole multi-
detector design and can obtain sensitivities in the order of 0.1%.
Preclinical PET cameras are downscaled models of human systems,
usually with an axial field-of-view that enables whole-body mouse
imaging. Spatial resolution in PET is around 1 mm and sensitivity
can be very high (14% is reported). Although SPECT offers several
advantages in study flexibility, radiochemistry complexity, tracer
half-lives and cost, PET is currently the most sensitive and quanti-
tatively accurate nuclear imaging modality [54].
Because SPECT/PET are considered quantitative imaging tech-
niques, image degrading effects, such as photon attenuation and
scatter should be corrected during the reconstruction process.
The reconstructed voxel size should be at least three times the spa-
tial resolution of the imaging system to minimize partial volume
effects [55]. Finally, SPECT/PET requires the injection of radioactive
tracers and cross-calibrations between SPECT/PET camera and a
dose calibration is required for accurate quantification [42,53]. This
requires imaging dedicated phantoms with a known activity con-
centration. The same can be used to assess longitudinal quantita-
tive accuracy of the scanner by comparing the known activity in
the phantom with that in the reconstructed images [42]. Tracer
Fig. 2. Typical workflow of small animal treatment planning. As an example, a target volume around the second thoracic mammary gland is defined (green contours, 3rd
row), and the heart is chosen as organ at risk (red contours, 3rd row). Firstly, information on electron and/or mass density and tissue type is acquired from an onboard CBCT
image (1st row) [4]. Upon image reconstruction, every voxel is assigned a density based on its Hounsfield Units (HU) and a suitable calibration phantom which also provides
tissue type information (2nd row) [27]. Secondly, the target volume (green) and potential organs at risk (red) need to be delineated by manual contouring (3rd row). Like for
segmentation (2nd row), no automated algorithms are so far available, thus adding a certain degree of arbitrariness to these procedures [27]. Thirdly, an isocenter and a set of
beams (static beams or arcs) are defined (4th row), and the TPS calculates the dose distribution. Finally, the results are reported as isodoses and dose–volume histograms (5th
row), and the delivery settings are transferred to the irradiator.
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volumes in small animals are limited, often requiring high activity
concentrations and, therefore, careful measurement of the injected
activity is crucial for accurate quantification.
Magnetic resonance imaging (MRI)
The clinical use of MRI is rapidly growing, i.e. forMR based treat-
ment planning including dose calculation, andmultiparametricMRI
for tissue characterization and response assessment. This trend is
based on advantages such as a superior soft-tissue contrast com-
pared to CT and imaging without dose burden, which also impacts
pre-clinical research [56–59].Maindisadvantages ofMRI are the rel-
atively longacquisition times and its implicationonanimal anesthe-
sia, the high cost of an MRI scanner and high operational costs.
In the standard irradiation setting, MRI scans are not directly
used for dose calculations, but a registered CT/MRI dataset pro-
vides the necessary information for targeting (MRI) and for dose
calculations (CT) [60]. Geometric aspects including distortion cor-
rections, scanner calibration and image registration need to be
considered, for which dedicated phantoms exist [42,61,62].
An MRI-only based workflow for radiotherapy planning becomes
feasible with the introduction of dedicated MRI sequences, such as
Ultra Short Echo time (UTE) and Zero Echo time (ZTE), where bony
structures become visible [57]. For this, a common coordinate sys-
tem between MRI images and micro-irradiator space is needed, e.g.
via 3D/3D (MR/CT) registration or using 2D/3D image registration
involving digitally reconstructed radiographs (DRRs).
Pre-clinical MR imaging is performed on dedicated micro-MR
systems, which often have ultra-high field strength, or on clinical
high field strength systems (i.e. 3T/7T) for which dedicated
micro-coils can achieve the high-spatial resolution [52,63]. The
high field strengths imply safety aspects. The resolutions of
micro-MR units are below 100 mm and the ultrahigh fields facili-
tate spectroscopy research. However, sequences and acquisition
protocols used for pre-clinical MRI need to be optimized toward
3D imaging to cover the whole tumor volume and to minimize dis-
tortion to guarantee geometric accuracy of the data.
Bioluminescence imaging (BLI)
For small animal radiotherapy BLI promises improved targeting
of tumors not visible on other modalities [64–66], as well as longi-
tudinal response-monitoring. While the BLI signal is weak, there is
no background and so it is able to detect as few as 1000 cells
injected in an animal. Also, it has a large dynamic range (several
orders of magnitude) without delivering any radiation dose [67,68].
A BLI signal can be acquired using non-contact optical imaging
or with optical fibers in contact with the tissue [69,70]. BLI col-
lected at multiple wavelengths can aid in target reconstruction,
since the signal is wavelength dependent (due to variations in tis-
sue absorption and scattering) [71].
While acquiring BLI images is straightforward, 3D source recon-
struction remains a challenge. With multiple techniques under
investigation, solutions that allow radiation targeting and response
monitoring can be expected in the near future.
Center-of-mass targeting using BLI is possible [72], but radia-
tion targeting requires the 3D geometry of the tumor. However,
the resolution and detection depth are limited by scattering of
optical photons and the limited knowledge of tissue optical prop-
erties [73]. The main 3D reconstruction needs (and limitations to
accurately achieving outcomes) are:
(a) a model of the surface and locations of detection points
[74,75] (using CBCT [76] or optical scanning)
(b) the location/geometry and optical properties of major
organs (requires segmentation on CBCT images; optical
properties either measured in situ using diffuse optical
tomography [77–80] or taken from library values [81])
(c) calculation of light propagation (using analytical [73,80] or
Monte Carlo methods [77,78])
(d) accurate reconstruction algorithm [78,79,81,82] (ill-posed
inverse problem)
Together, these steps take considerable time (10–20 min per
mouse) that would severely reduce throughput on a system. The
process speed for radiation targeting could be improved using
accurate auto-segmentation or BLI could be performed at a sepa-
rate session prior to treatment with the target transferred to treat-
ment images using deformable registration.
Registration of different imaging modalities
To fully exploit the high precision of small animal image-guided
radiotherapy the positioning error of the target has to be mini-
mized. This may require registration of information from various
images, possibly from different modalities, usually to a reference
CBCT image. This can be done manually or ideally by software to
provide spatial registration of the two images by optimization of
a ‘goodness-of-alignment’ metric using appropriate features. Both
rigid transformations (only translation and/or rotation) and non-
rigid transformations may be needed to allow for changes in size
and/or shape of sub-volumes. Although potentially providing bet-
ter registration, care must be taken when employing the latter to
ensure deformations are realistic. Relevant information that should
be reported is detailed in Table S2 Additionally, non-rigid registra-
tion can be used in longitudinal studies between the initial CBCT
image and subsequent scans. This can be used to follow accurately
the deformation of organ contours [83].
Depending on which part of the body is being studied, move-
ments may be a major limiting factor to using co-registered images
for targeting. While the anatomy of the head remains relatively
immobile, significant motion is possible within the abdomen and
thorax with time and as a result of handling. In these cases it is
essential that procedures are in place to minimize movement
between initial imaging and subsequent beam delivery. Recom-
mendations to help ensure accuracy of registration and minimize
the effect of movement are summarized in Table S5.
Table 4
Data sets and standards for various preclinical and clinical fields.
Domain Data set Applicable standard
Molecular and clinical data The Cancer Genome Atlas (TCGA) molecular and clinical data N/A
Clinical imaging The Cancer Imaging Archive (TCIA) in vivo imaging data DICOM
Pre-clinical Small animal models Suppl 187: Preclinical Animal Imaging Acquisition Context of the
DICOM standard exists but has not yet been adopted
Digital pathology caMicroscope DICOM is applicable but has not yet been adopted
All Annotations and markup on images lAIM is in development
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Digital data processing
In the medical field data standards have been used for many
years allowing for standardized storage and easy exchange
between different systems and different clinics. In medical imag-
ing, the DICOM standard (Digital Imaging and Communication in
Medicine, [84]) was set up to address this and for clinical applica-
tions today the DICOM standard is well established among medical
imaging equipment vendors and healthcare IT organizations. In the
field of preclinical radiobiology and trials, however, far less effort
has been put in data standardization, which has hampered data
sharing and leveraging results across studies and institutes.
Imaging-based cancer research is in the early phase of an
integrative-biology revolution making the creation of more robust
tools crucial for data interoperability across several domains like
genomics (and other omics), diagnostic imaging, and digital
pathology (Table 4). The newly available image-guided precision
irradiation research platforms present a unique opportunity to
develop data standards and powerful data analysis tools that will
enable more efficient data extraction and data processing.
Indeed, some of the modern small animal platforms and treat-
ment planning systems already support the DICOM standard for
imaging and the DICOM-RT objects (RT Image, RT Structure Set,
RT Plan, RT Dose,. . .). Recent efforts by the DICOM working group
30 have led to a DICOM standard Supplement 187 defining use-
cases and templates for storage of information related to acquisi-
tion of small animal images during preclinical research ([85],
Table S6). A common informatics infrastructure for small animal
research must also provide researchers with a data warehouse
combining various sources of data for easy storage and retrieval
of large amounts of information such as pathology, genomics, his-
tology, experimental designs, etc. In addition, a modern software
environment for small animal studies should provide analysis tools
that can be used to directly mine data from multiple high-volume
information repositories, creating a foundation for research and
translation of the results of animal studies into clinical trials.
Particle beam studies
As dedicated small animal irradiation devices are available only
for photons, particle irradiations of animals are currently per-
formed in clinical or experimental facilities [86–89]. Also, current
TPS are usually not intended to be used for small irradiation fields
and integrated imaging devices are mostly not available or not
suitable for small animal irradiations with particles except in rare
cases [90]. This compromises dosimetric and geometric irradiation
accuracy. Together with limited experience with particle beams,
this may affect the results and complicate inter-comparison of data
between different facilities.
Many requirements for specification and reporting of precision
small animal particle irradiations are similar to those of photons,
however, particle irradiations require specification and reporting
of several additional parameters (Table 2). When using a clinical
TPS, one should be aware of the potentially limited accuracy of
the predicted absolute dose and lateral field borders. In this respect,
verification measurements by pinpoint ionization chambers and
radiochromic filmsmay be necessary [87]. When comparing results
with photon experiments, the use of identical dose prescription
points, dose verification methods and field sizes has to be assured.
In general, small animal irradiation studies should take care
that there is a close link to clinical particle beam protocols to
assure that results replicate patient exposures. As it is unlikely that
there will be many dedicated small animal irradiation facilities in
the near future, researchers are encouraged to develop and install
dedicated TPS and imaging devices for small animal irradiations at
their clinical or experimental beam lines to improve dosimetric
and geometric accuracy [90].
Conclusions
It is strongly recommended to develop protocols and guidelines
to use the novel preclinical radiation research platforms to maxi-
mize their impact on translation of radiotherapy research into
the clinic. This report provides an overview of the relevant technol-
ogy issues to consider.
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